Sign In

Erik Kinnman

Chief Executive Officer at Vivesto

Erik Kinnman is a seasoned Medical Doctor with 28 years of experience in the pharmaceutical industry, currently serving as the CEO at Vivesto.

Throughout his career, Erik has held executive positions at renowned organizations such as Sprint Bioscience, Abliva, AstraZeneca, and SOBI, showcasing expertise in clinical development, medical affairs, business strategy, financing, and board director roles.

Erik Kinnman is board certified in Neurology and Pain Management and holds the title of Associate Professor at Karolinska Institutet, alongside his academic achievements which include an MBA.

His educational background ranges from executive finance programs at INSEAD to a Medical Doctorate and PhD from Karolinska Institutet, reflecting his commitment to continuous learning and professional development.

Erik has a diverse organizational footprint, having served in various capacities such as CEO, Board Member, and Chief Medical Officer at companies like Stayble, Immune System Regulation AB, and Kinnman Life Science Solutions AB.

Prior to his current roles, Erik gained valuable experience at prominent pharmaceutical firms including AstraZeneca, Sanofi-Synthelabo, Pfizer, and Swedish Orphan Biovitrum AB, covering areas such as medical direction, business strategy, and investor relations.

His career trajectory includes international exposure with a postdoctoral fellowship at the University of California, San Francisco, further enriching his expertise in the healthcare landscape.

Erik Kinnman
Add to my network

Location

Solna, Stockholm County, Sweden